Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    2046917 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects
Conditions: Parkinson Disease;   Alzheimer Disease;   Healthy Controls;   Multiple Sclerosis
Intervention: Drug: [123I]CLINDE

Study has passed its completion date and status has not been verified in more than two years.